Weight Loss
Weight Watchers Goes All-In on GLP-1s With App Overhaul
The new Weight Watchers app combines GLP-1 prescriptions with personalized nutrition tools, coaching and strength training offerings.
Noom Eyes GLP-1s for Longevity, Not Just Weight Loss
Noom’s microdose GLP-1 program targets early metabolic risk and longevity, offering weight-loss drugs to adults with a BMI of 21 or higher.
GLP-1 Stigma Fades Through Personal Ties, Survey Shows
A new Ro survey shows GLP-1 stigma falls when people know someone taking the medication, suggesting personal ties are driving acceptance.
Fitness Stakeholders Urge Strength Training for GLP-1 Users
Les Mills and ukactive are urging the healthcare and fitness sectors to promote strength training and adequate protein intake for people taking weight-loss drugs.
WHO Endorses GLP-1 Drugs for Weight Loss in Major Policy Shift
Popular drugs like Ozempic are now a part of official global health recommendations from the World Health Organization to treat obesity.
Popular Fitness Apps May Actually Reduce Motivation, Study Finds
Researchers found that tracking apps like MyFitnessPal sometimes play a factor in promoting unrealistic goals and feelings of shame, leading […]
GLP-1s Could Reduce US Deaths by 9% in Best Case Scenario, Report Finds
Anti-obesity medications like GLP-1s have the potential to significantly reduce mortality in countries across the globe, per a new report.
GNC Pushes To Make Supplements Part of the GLP-1 Conversation
GNC's new peer-reviewed research shows how supplements can support GLP-1 takers in preserving muscle mass loss and plugging nutrition gaps.
GLP-1 Use Doubles Across America — Here’s Who’s Taking Them
New Gallup data shows GLP-1 use has doubled nationwide as telehealth startups and investors are reshaping the weight-loss market.
ATN Week in Review: US Gyms Keep Winning, Raising Cash
This week, we break down more good news for America's big-box gyms, and look into the complexities surrounding the U.S.'s obesity crisis.
